LyGenesis Competitors and Similar CompaniesClear all
LyGenesis's competitors and similar companies include Kallyope, Novacyt and Palleon Pharmaceuticals.
 LyGenesis LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs. |  Novacyt Novacyt is active in developing, manufacturing and marketing advanced and innovative solutions for cytology. |  Palleon Pharmaceuticals Palleon Pharmaceuticals is a biotechnology company focused on developing Glycoimmune Checkpoint inhibitors to treat cancer. | ||
Founding Date | Founding Date 2017 | Founding Date 2015 | Founding Date N/A | Founding Date 2016 |
Type | Type Private | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations Pittsburgh, US HQ Pittsburgh, US | Locations New York, US HQ | Locations Vélizy-Villacoublay, FR HQ Camberley, GB Chandler's Ford, GB | Locations Waltham, US HQ |
Employees | Employees 7 | Employees 70 | Employees 234 | Employees 25 |
Funding | ||||
Latest funding round | Latest funding round $ 4m (over 6 years ago) | Latest funding round $ 112m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 100m (almost 6 years ago) |
Total funding raised | Total funding raised $ 7m | Total funding raised $ 243m | Total funding raised $ 11.6m | Total funding raised $ 147.6m |
For sources of this data, please see the company profile
View Company Profiles
Novacyt
HQ
Vélizy-Villacoublay, FR
Employees
234
Novacyt is active in developing, manufacturing and marketing advanced and innovative solutions for cytology.
View companyPalleon Pharmaceuticals
HQ
Waltham, US
Employees
25
Palleon Pharmaceuticals is a biotechnology company focused on developing Glycoimmune Checkpoint inhibitors to treat cancer.
View company